Home LiteratureArticle Details
PMID: 29382944 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

APLP1 is endoproteolytically cleaved by γ-secretase without previous ectodomain shedding.

Scientific reports ·Vol. 8 ·No. 1 ·2018-00-30 ·页码 1916

Schauenburg L, Liebsch F, Eravci M, Mayer MC, Weise C, Multhaup G

Abstract

Regulated intramembrane proteolysis of the amyloid precursor protein (APP) and its homologs, the APP like proteins APLP1 and APLP2, is typically a two-step process, which is initiated by ectodomain-shedding of the substrates by α- or β-secretases. Growing evidence, however, indicates that the cleavage process for APLP1 is different than for APP. Here, we describe that full-length APLP1, but not APP or APLP2, is uniquely cleaved by γ-secretase without previous ectodomain shedding. The new fragment, termed sAPLP1γ, was exclusively associated with APLP1, not APP, APLP2. We provide an exact molecular analysis showing that sAPLP1γ was uniquely generated by γ-secretase from full-length APLP1. Mass spectrometry analysis showed that the sAPLP1γ fragment and the longest Aβ-like peptide share the C-terminus. This novel mechanism of γ-secretase action is consistent with an ϵ-cut based upon the nature of the reaction in APP. We further demonstrate that the APLP1 transmembrane sequence is the critical determinant for γ-shedding and release of full-length APLP1. Moreover, the APLP1 TMS is sufficient to convert larger type-I membrane proteins like APP into direct γ-secretase substrates. Taken together, the direct cleavage of APLP1 is a novel feature of the γ-secretase prompting a re-thinking of γ-secretase activity modulation as a therapeutic strategy for Alzheimer disease.

MeSH 主题词
Amyloid Precursor Protein Secretases/metabolism Amyloid beta-Protein Precursor/metabolism Cell Line HEK293 Cells Humans Membrane Proteins/metabolism
化学物质
APLP1 protein, human Amyloid beta-Protein Precursor Membrane Proteins Amyloid Precursor Protein Secretases
作者与单位
共 6 位作者,点击展开单位 / ORCID
Schauenburg Linda
Institut für Chemie und Biochemie, Freie Universität Berlin, Thielallee 63, 14195, Berlin, Germany. | Sphingotec Therapeutics GmbH, Neuendorfstr. 15a, 16761, Hennigsdorf, Germany.
Liebsch Filip ORCID
Department of Pharmacology & Therapeutics and Integrated Program in Neuroscience, McGill University, 3655 Promenade Sir William Osler, Montreal, QC, H3G 1Y6, Canada.
Eravci Murat
Institut für Chemie und Biochemie, Freie Universität Berlin, Thielallee 63, 14195, Berlin, Germany.
Mayer Magnus C
Institut für Chemie und Biochemie, Freie Universität Berlin, Thielallee 63, 14195, Berlin, Germany. | Miltenyi Biotec GmbH, Robert-Koch-Strasse 1, 17166, Teterow, Germany.
Weise Christoph
Institut für Chemie und Biochemie, Freie Universität Berlin, Thielallee 63, 14195, Berlin, Germany.
Multhaup Gerhard
Institut für Chemie und Biochemie, Freie Universität Berlin, Thielallee 63, 14195, Berlin, Germany. gerhard.multhaup@mcgill.ca. | Department of Pharmacology & Therapeutics and Integrated Program in Neuroscience, McGill University, 3655 Promenade Sir William Osler, Montreal, QC, H3G 1Y6, Canada. gerhard.multhaup@mcgill.ca.
Article Info
Journal
Scientific reports
Abbr.
Sci Rep
ISSN
2045-2322
Corresponding email
Published
2018-00-30
电子出版
2018-00-30
页码
1916
Language
English
Country/Region
England
NLM ID
101563288
基金资助
CIHR · MOP-133411 · Canada
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com